Chinese Woman Tests Positive for COVID-19 Four Times a Year
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
- Statins Lower Blood Lipids: How Long is a Course?
- Warning: Smartwatch Blood Sugar Measurement Deemed Dangerous
Chinese Woman Tests Positive for COVID-19 Four Times a Year, Diagnosed with Good Syndrome – a First in China
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Chinese Woman Tests Positive for COVID-19 Four Times a Year, Diagnosed with Good Syndrome – a First in China
A 54-year-old woman named Ms. Liu, living in Liuzhou City, Guangxi Zhuang Autonomous Region in southwestern China, tested positive for COVID-19 four times in one year and was finally diagnosed with Good syndrome. Good syndrome is a rare disease, affecting one in a million people, and was identified as the cause of her repeated positive tests.
Ms. Liu was troubled by testing positive for COVID-19 four times in just one year. Determined to find the cause, she visited the Department of Respiratory and Critical Care Medicine at the First Affiliated Hospital of Guangxi Medical University in Nanning, Guangxi.
During her hospitalization, it was discovered that Ms. Liu had an extremely low immune level. Dr. Wang Ke, chief physician, analyzed her medical history in detail and found various clues. Two years ago, Ms. Liu had surgery for thymoma, and within six months, she suffered from recurrent pityriasis versicolor (a chronic and recurrent disease affecting the skin and mucous membranes) and sinusitis, along with repeated diarrhea and gradual weight loss.
Based on this fragmented information, Dr. Wang concluded that Ms. Liu’s symptoms matched those of Good syndrome. Good syndrome is an autoimmune deficiency disease characterized mainly by thymoma and hypogammaglobulinemia, with an incidence rate of approximately 1.5 individuals per million. Due to its rarity and insidious nature, it is difficult to diagnose, and some patients may die from severe infections.
After discussions among medical professionals both online and offline, Ms. Liu was ultimately diagnosed with Good syndrome. As of the 18th, she was the first confirmed case in China of a patient with Good syndrome recurring with COVID-19 infection.
Once the diagnosis was confirmed, the medical team developed a treatment plan mainly for Ms. Liu’s low immunity. After more than ten days, her symptoms completely improved, and she was discharged safely. Subsequently, to enhance her immune system, Ms. Liu needs monthly injections of immunoglobulin for a long period.
Most Good syndrome patients develop the disease between the ages of 40 and 70, regardless of gender. This disease was first discovered in 1954, and its cause is still unknown.
Over the past decade, improvements in the clinical understanding of rare diseases, the widespread use of immunoglobulin replacement therapy, the extensive application of various antimicrobial drugs, and better supportive therapy are said to have significantly reduced the mortality rate of this disease in the medical community.
Chinese Woman Tests Positive for COVID-19 Four Times a Year, Diagnosed with Good Syndrome – a First in China
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
